PR Newswire#pr
Senhwa's CX-5461 Opens a New Frontier in Photoimmunotherapy; Multinational Study Published in Nucleic Acids Researchtranslating…
3h agoFactuality: 70/100USACision
TAIPEI and SAN DIEGO, Aug. 12, 2026 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492) today announced a significant research advance involving its investigational drug Pidnarulex (CX-5461). A multinational research team comprising investigators from Poland, Slovakia, France…